During the registration process, you will be asked to provide personal details to assist us in planning the event. These details will also be confirmed back to you in an initial and final confirmation emails and reminder text messages that you will receive from TSA Events. In order to make the appropriate arrangements for your attendance at the event, we are required to share certain personal details with:
(a) the event organiser (Alcon)
(b) our event suppliers for these arrangements to be made and confirmed; and
(c) suppliers of services to us (e.g. IT service providers) where necessary for us to process your personal information and make the relevant arrangements.
(d) third parties associated with the event, by way of sponsorship or exhibitor agreement directly with Alcon.
Only those personal details required for certain suppliers will be passed along in a secure method and in accordance with Alcon event policy.
By providing your personal information to Alcon Laboratories (Australia) Pty Ltd or its related bodies corporate (Alcon), you consent to Alcon collecting, storing and using your personal information in accordance with the Alcon Privacy Policy. In particular, you consent to Alcon using your personal information to communicate with you about Alcon products and/or to support your use of those products. You also consent to Alcon using your personal information to (where applicable) invite you to, or arrange your participation in, activities managed by (or on behalf of) Alcon. Alcon is committed to patient safety. In accordance with regulatory obligations, Alcon has a systematic process in place to collect, store and process reports of adverse events experienced by patients taking a Alcon product, when identified by an Alcon representative (or by a third party acting on behalf of Alcon). All information forwarded to the Alcon drug safety department is treated in accordance with local privacy laws and may be captured and processed in countries outside of the national territory, and shared with health authorities or other Pharmaceutical companies with whom Alcon has a license agreement, for the purpose of meeting the regulatory requirements for reporting safety information on Alcon products. Alcon drug safety department may contact the patient’s healthcare professional in order to collect further information on the adverse event. You are not obliged to provide personal information. However, if you do not provide information you may not, for example, be able to participate fully in activities managed by us. You have the right to access, update or correct your personal information and/or decline to receive communications from Alcon. To find out how, please refer to our Privacy Policy at https://www.alcon.com/privacy-policy or contact our Privacy Officer at Alcon Australia, Suite 1, Level 7 15 Talavera Road Macquarie Park NSW 2113. Phone: +61 (2) 9452 9200. Email: privacy@alcon.com
© 2026 Alcon Inc. Alcon Laboratories (Australia) Pty Ltd: 1800 224 153. Auckland NZ: 0800 101 106.
